A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexMale

Age19+

SponsorAddpharma Inc.

About this trial

This study compares and evaluates the bioequivalence of AD-116A and AD-1161 in healthy adult male volunteers under fed conditions.

Body weight equal to or greater than 50 kg and body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit

Age equal to or greater than 19 years in healthy adult male volunteers at the time of screening visit

Participation in another clinical study with an investigational drug within 6 months prior to the scheduled first administration

Other exclusions applied

44 Participants

are divided into 2 treatment groups

Addpharma Inc.

Lead sponsor